Plasma Concentrations and Renal Clearance of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Cancer Patients Receiving Morphine

[1]  S. Joel,et al.  The analgesic activity of morphine-6-glucuronide. , 1992, British journal of clinical pharmacology.

[2]  A. Somogyi,et al.  The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients. , 1992, British journal of clinical pharmacology.

[3]  A. Somogyi,et al.  Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[4]  A. Somogyi,et al.  High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies. , 1991, Journal of chromatography.

[5]  F. Takeda.  Who cancer pain relief programme , 1990, Pain.

[6]  J. Mørland,et al.  Morphine-6-Glucuronide might Mediate the Prolonged Opioid Effect of Morphine in Acute Renal Failure , 1990, Human & experimental toxicology.

[7]  D. Gavaghan,et al.  Oral morphine in cancer pain: influences on morphine and metabolite concentration , 1990, Clinical pharmacology and therapeutics.

[8]  S. Joel,et al.  Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine‐6‐glucuronide , 1990, Clinical pharmacology and therapeutics.

[9]  G. Pasternak,et al.  Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. , 1989, The Journal of pharmacology and experimental therapeutics.

[10]  J. Hasselström,et al.  Long lasting respiratory depression induced by morphine-6-glucuronide? , 1989, British journal of clinical pharmacology.

[11]  G. Aherne,et al.  Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients. , 1988, British journal of anaesthesia.

[12]  S. Joel,et al.  ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDE , 1988, The Lancet.

[13]  A. Somogyi,et al.  Pharmacokinetic drug interactions between triamterene and ranitidine in humans: alterations in renal and hepatic clearances and gastrointestinal absorption. , 1988, The Journal of pharmacology and experimental therapeutics.

[14]  G. Pasternak,et al.  Morphine-6-glucuronide, a potent mu agonist. , 1987, Life sciences.

[15]  M. Slevin,et al.  Morphine intoxication in renal failure; the role of morphine-6-glucuronide. , 1986, British medical journal.

[16]  S. Braver,et al.  The measurement of clinical pain intensity: a comparison of six methods , 1986, Pain.

[17]  L. Kager,et al.  Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. , 1985, British journal of clinical pharmacology.

[18]  J. Svensson,et al.  Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence. , 1983, British journal of clinical pharmacology.

[19]  F. Roch-Ramel,et al.  Transport and metabolism of [3H]morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney. , 1982, The Journal of pharmacology and experimental therapeutics.

[20]  C. B. Christensen,et al.  Plasma morphine concentrations during chronic oral administration in patients with cancer pain , 1982, PAIN.

[21]  W. Bennett,et al.  Morphine and phenytoin binding to plasma proteins in renal and hepatic failure , 1975, Clinical pharmacology and therapeutics.

[22]  G. Olsen.  Morphine binding to human plasma proteins , 1975, Clinical pharmacology and therapeutics.

[23]  K. Oguri,et al.  Analgesic effect of morphine glucuronides. , 1971, The Tohoku journal of experimental medicine.

[24]  J. Fujimoto,et al.  The tubular transport and metabolism of morphine-N-methyl-C14 by the chicken kidney. , 1967, The Journal of pharmacology and experimental therapeutics.

[25]  A. Somogyi,et al.  Mu receptor binding of some commonly used opioids and their metabolites. , 1991, Life sciences.

[26]  P. Glare,et al.  Clinical pharmacokinetics of morphine. , 1991, Therapeutic drug monitoring.

[27]  C. Woolf,et al.  Proceedings of the 11th World Congress on Pain , 1991 .

[28]  Maree T. Smith,et al.  Morphine-3-glucuronide--a potent antagonist of morphine analgesia. , 1990 .

[29]  R. Palmour,et al.  Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. , 1988, Life sciences.

[30]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .